Cargando…

Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study

OBJECTIVES: We evaluated the cost-effectiveness of a 12-month regimen of oral capecitabine versus a standard 6-month regimen as postoperative adjuvant chemotherapy for stage III colon cancer. METHODS: We utilized patient-level data from a multi-institutional randomized controlled trial (JFMC37-0801)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shibahara, Hidetoshi, Shiroiwa, Takeru, Ishiguro, Megumi, Nakamura, Masato, Hasegawa, Junichi, Yamaguchi, Shigeki, Masuda, Yuriko, Sakamoto, Junichi, Tomita, Naohiro, Fukuda, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395498/ https://www.ncbi.nlm.nih.gov/pubmed/35072852 http://dx.doi.org/10.1007/s10198-021-01418-6

Ejemplares similares

Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer
por: Suto, Takeshi, et al.
Publicado: (2017)

Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study
por: Tomita, Naohiro, et al.
Publicado: (2019)

Healthcare costs for the elderly in Japan: Analysis of medical care and long-term care claim records
por: Akiyama, Naomi, et al.
Publicado: (2018)

Construction estimating and job preplanning
por: Deatherage, George E.
Publicado: (1965)

Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials
por: Shiroiwa, T, et al.
Publicado: (2009)

Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902)
por: Katsuno, Hidetoshi, et al.
Publicado: (2015)

A comparison of preplan MRI and preplan CT-based prostate volume with intraoperative ultrasound-based prostate volume in real-time permanent brachytherapy
por: Park, Hyeli, et al.
Publicado: (2011)

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial
por: Shiroiwa, T, et al.
Publicado: (2011)

EQ-5D-Y Population Norms for Japanese Children and Adolescents
por: Shiroiwa, Takeru, et al.
Publicado: (2021)

Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial)
por: Okuno, Kiyotaka, et al.
Publicado: (2017)

A preplanning method for stereotactic radiosurgery to improve treatment workflow
por: Ahn, Kang‐Hyun, et al.
Publicado: (2016)

Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003)
por: Tanaka, Hiroaki, et al.
Publicado: (2017)

Comparative Geno-Plasticity Analysis of Mycoplasma bovis HB0801 (Chinese Isolate)
por: Qi, Jingjing, et al.
Publicado: (2012)

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer
por: Peng, Jingyuan, et al.
Publicado: (2018)

Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
por: Kotaka, Masahito, et al.
Publicado: (2015)

Cost-effectiveness study of early versus late parenteral nutrition in critically ill children (PEPaNIC): preplanned secondary analysis of a multicentre randomised controlled trial
por: van Puffelen, Esther, et al.
Publicado: (2018)

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial
por: Shiroiwa, Takeru, et al.
Publicado: (2017)

WTP for a QALY and health states: More money for severer health states?
por: Shiroiwa, Takeru, et al.
Publicado: (2013)

Estimation of Lifetime QALYs Based on Lifestyle Behaviors
por: Noto, Shinichi, et al.
Publicado: (2021)

Glycolysis is suppressed by DCZ0801-induced inactivation of the Akt/mTOR pathway in Multiple Myeloma
por: Feng, Qilin, et al.
Publicado: (2020)

Preplanning Vascularized Lymph Node Transfer with Duplex Ultrasonography: An Evaluation of 3 Donor Sites
por: Patel, Ketan M., et al.
Publicado: (2014)

Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) clinical trials
por: Maeda, Hiromichi, et al.
Publicado: (2017)

Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer
por: Eggington, S, et al.
Publicado: (2006)

Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)
por: Matsusaka, Satoshi, et al.
Publicado: (2015)

Characteristics of preplan‐based three‐dimensional individual template‐guided brachytherapy compared to freehand implantation
por: Zhang, Bin, et al.
Publicado: (2022)

Valuation Survey of EQ-5D-Y Based on the International Common Protocol: Development of a Value Set in Japan
por: Shiroiwa, Takeru, et al.
Publicado: (2021)

Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens
por: Hansen, Ryan N, et al.
Publicado: (2014)

Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: She, Longjiang, et al.
Publicado: (2022)

Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)
por: Matsusaka, Satoshi, et al.
Publicado: (2015)

OA08.01. Cholecystokinin antagonizes opioid function during electroacupuncture inhibitory effect on pressor reflex in rats
por: Li, M, et al.
Publicado: (2012)

Prospective Observational Study of High-Dose Carbon-Ion Radiotherapy for Pelvic Recurrence of Rectal Cancer (GUNMA 0801)
por: Shiba, Shintaro, et al.
Publicado: (2019)

Capecitabine for primary breast cancer
por: Toi, Masakazu, et al.
Publicado: (2017)

A cost‐effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan
por: Miki, Norikane, et al.
Publicado: (2021)

Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane‐ and trastuzumab‐naïve patients with HER2‐positive, previously treated, advanced, or recurrent gastric cancer (JFMC45‐1102)
por: Nishikawa, Kazuhiro, et al.
Publicado: (2016)

Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan
por: Lin, Yu-Ju, et al.
Publicado: (2021)

Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201)
por: Sadahiro, Sotaro, et al.
Publicado: (2022)

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial
por: Ricardi, Umberto, et al.
Publicado: (2021)

Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment
por: Xue, Liting, et al.
Publicado: (2021)

Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
por: Ueno, Takayuki, et al.
Publicado: (2018)

Development of a multiplicative, multi-attribute utility function and eight single-attribute utility functions for the Health Utilities Index Mark 3 in Japan
por: Noto, Shinichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_19n14upramot6b9qrqkgog4th0